Clinical trial
Neuroprotective Effect of Butylphthalide Injection on Patients With Return of Spontaneous Circulation After Cardiac Arrest:a Multicenter, Randomized Clinical Trial
NCT06572085 is registered in ClinicalTrials.gov with Tang Ziren as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neuroprotective Effect of Butylphthalide Injection on Patients With Return of Spontaneous Circulation After Cardiac Arrest:a Multicenter, Randomized Clinical Trial
- Lead sponsor
- Tang Ziren
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- January 1, 2022
- Completion date
- December 31, 2027
- Enrollment
- 350 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
butylphthalide, cardiac arrest, neuroprotective drugs